NEW YORK, Dec. 9, (GenomeWeb News) - The National Cancer Institute intends to commit around $10 million in 2006 to fund approximately 10 new grants as part of its Clinical Proteomic Technologies Initiative, the institute said today.
In an RFA posted on its web site, the institute invites grant applications for "highly innovative research in the quantitative analysis of proteins and peptides of interest" in clinical cancer studies.
GenomeWeb News reported in October NCI's notice of intent for RFAs for advanced proteomic platforms, analytical methods, and computational sciences.
Titled "Advanced Proteomic Platforms and Computational Sciences for the NCI Clinical Proteomic Technologies Initiative," the RFA has receipt dates in early spring of 2006.
NCI described the technologies initiative as an "integrated approach to develop and enhance proteomic technology capabilities" on its web site.
More information can be found here.